Intellia Therapeutics Head office building

SEC Filing
Details

Document Details

Filing Date
May 5, 2016
Document Date
May 5, 2016
Form Description
Registration of up to an additional 20% of securities for any offering registered on an S-1
Filing Group
Registration Statements
Company
Intellia Therapeutics
Issuer
Intellia Therapeutics, Inc.